# Interest of a Tetanus Test at a Fixed Remifentanil Concentration Before Laryngoscopy and Skin Incision

> **NCT02884310** · PHASE4 · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 48 (actual)

## Conditions studied

- Intravenous Anesthetic Agent Overdose

## Interventions

- **DRUG:** Remifentanil adapted to SPI
- **DRUG:** Remifentanil fixed

## Key facts

- **NCT ID:** NCT02884310
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-12
- **Final completion:** 2016-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02884310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02884310, "Interest of a Tetanus Test at a Fixed Remifentanil Concentration Before Laryngoscopy and Skin Incision". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02884310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*